What is the Anti-Bribery PECB Insights Conference about?

The second PECB Insights Conference will bring together experts, practitioners, and influencers to continue elevating our professional competencies. Exclusively, the PECB Insights Conference held in Montreal, Canada on 13-14 November 2017, will specialize in Anti-Bribery.

The theme will extend to facilitate learning through an outstanding professional opportunity. The second session of PECB Insights Conference will strive to provide its attendees with a unique knowledge sharing experience. The Anti-Bribery PECB Insights Conference is organized to be attended in three different tracks, such as Anti-Bribery in Politics, Anti-Bribery in Corporations, and Investigations.

Find out more about this event, or click here for registration!

One-time offer! Get a 100% discount on your PECB Anti-Bribery Conference ticket. This offer is valid until the 31st October 2017.

Extend your stay in Montreal and become a certified ISO 37001 Lead Implementer with ContinuityLink

Join us after the Conference for the ISO 37001 Anti-Bribery Lead Implementer training and certification.

Quebec is one of the first places in the world where companies and public bodies can go to school to learn a new international standard for fighting corruption!

The new ISO 37001 standard specifies a series of internal processes and policies to help organizations prevent, detect and address bribery, including adopting whistleblower protection, developing ethics policies, appointing an internal compliance officer, providing training for employees to combat bribery, conducting risk assessments, setting up internal financial controls and developing procedures to report and investigate deviations.

The English version of this training and certification is offered exclusively by ContinuityLink. Next session in Montreal is on 20-24 November 2017. Do you want to become a certified ISO 37001 Lead Implementer? Book your seat today!

Find out more about this course, and click here for registration!

1 Comment »

Leave a Reply